中文 | English
Return
Total: 77 , 1/8
Show Home Prev Next End page: GO
Author:(Hongqing ZHANG)

1.Application of proteomics in research for gastrointestinal tumors

Hongqing ZHUO ; Hui ZHANG ; Shan WANG

International Journal of Surgery 2012;39(3):196-199

2.The mechanism of itraconazole as an anticancer agent

Zeying FAN ; Xiaodong ZHANG ; Hongqing CHEN

Journal of International Oncology 2017;44(2):136-138

4.Study of the effect of methotrexate and cyclophophamide on cell cycle and cyclin DI of lymphocytes in the periphery blood and bone marrow in rats

Jinli RU ; Xiaofeng LI ; Xin WANG ; Hongqing NIU ; Liyun ZHANG

Chinese Journal of Rheumatology 2009;13(8):541-544

5.Effect of different anesthetic techniques on perioperative changes in T-lymphocyte subsets in patients with cardia cancer

Xiaojia ZHANG ; Qinqing HU ; Hongqing LI ; Minru DENG

Chinese Journal of Postgraduates of Medicine 2010;33(30):14-16

6.Significance of β-catenin and Cyclin D1 express in glioma

Zhiqiang ZHANG ; Hongqing CHEN ; Yinghong CHEN ; Xinfu CHENG

Journal of Cellular and Molecular Immunology 2009;25(11):1010-1012

7.Experimental study of motor nerve innervation of uvala muscle

Weijian ZHONG ; Hongqing WANG ; Kuiqi ZHANG

Chinese Journal of Stomatology 2001;36(3):197-198

8.ECM1 Gene Mutations in a Family with Lipoid Proteinosis

Changyuan WANG ; Pingzhao ZHANG ; Furen ZHANG ; Jie LIU ; Hongqing TIAN ; Long YU

Chinese Journal of Dermatology 2003;0(11):-

9.Superiority, Confusion and Countermeasures to DCD WeChat Ethical Review

Lan LI ; Guishu CHEN ; Shaohong YU ; Yongheng ZHAO ; Chao LI ; Riuhong ZHANG ; Hongqing ZHANG ; Wenhu JIANG

Chinese Medical Ethics 2016;29(2):288-290

10.Association of killer cell immunoglobulin-like receptor genes 2DS4 and its variant KIR1D with syphilis

Yunlong ZHUANG ; Yi ZHANG ; Yonghong SONG ; Hongqing TIAN ; Xiangmin NIE ; Yan LIU ; Chuanfu ZHU

Chinese Journal of Microbiology and Immunology 2011;31(6):549-553

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 77 , 1/8 Show Home Prev Next End page: GO